The endothelin axis in cancer

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 8, 2008, Pages 1443-1451

  Bagnato, Anna ^a   Rosanò, Laura ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Antitumor therapy; Endothelin; Endothelin receptor antagonist; G protein coupled receptor

Indexed keywords

ATRASENTAN; CYTOTOXIC AGENT; ENDOTHELIN 1; GEFITINIB; N (3 METHOXY 5 METHYL 2 PYRAZINYL) 2 [4 (1,3,4 OXADIAZOL 2 YL)PHENYL] 3 PYRIDINESULFONAMIDE; PACLITAXEL;

BLADDER CANCER; BONE DEVELOPMENT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; COLON CANCER; GLIOBLASTOMA; HUMAN; IMMUNOMODULATION; KAPOSI SARCOMA; LUNG CANCER; MELANOMA; NASOPHARYNX CANCER; NEOVASCULARIZATION (PATHOLOGY); NEUROBLASTOMA; OVARY CARCINOMA; PROSTATE CARCINOMA; PROTEIN SYNTHESIS; SHORT SURVEY; UTERINE CERVIX CANCER;

CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELINS; FEMALE; GTP-BINDING PROTEINS; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RECEPTOR, ENDOTHELIN A; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

EID: 43049100321     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.01.022     Document Type: Short Survey

References (27)

1. Akhavan A., McHugh K.H., Guruli G., Bies R.R., Zamboni W.C., Strychor S.A., et al. Endothelin receptor A blockade enhances taxane effects in prostate cancer. Neoplasia 8 (2006) 725-732
2. Bagnato A., Cirilli A., Salani D., Simeone P., Muller A., Nicotra M.R., et al. Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Research 62 (2002) 6381-6384
3. Bagnato A., Rosanò L., Spinella F., Di Castro V., Tecce R., and Natali P.G. Endothelin B receptor blockade inhibits dynamic of cell interactions and communications in melanoma cell progression. Cancer Research 64 (2004) 1436-1443
4. Bagnato A., Spinella F., and Rosanò L. Emerging role of the endothelin axis in ovarian tumor progression. Endocrine-Related Cancer 12 (2005) 761-772
5. Carducci M.A., and Jimeno A. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clinical Cancer Research 12 (2006) 6296s-6300s
6. Davar G. Endothelin-1 and metastatic cancer pain. Pain Medicine 2 (2001) 24-27
7. Del Bufalo D., Di Castro V., Biroccio A., Varmi M., Salani D., Rosanò L., et al. Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: Requirement for Akt activation. Molecular Pharmacology 61 (2002) 524-532
8. Egidy G., Eberl L.P., Valdenaire O., Irmler M., Majdi R., Diserens A.C., et al. The endothelin system in human glioblastoma. Laboratory Investigation 80 (2000) 1681-1689
9. Grimshaw M.J. Endothelins and hypoxia-inducible factor in cancer. Endocrine-Related Cancer 14 (2007) 233-244
10. Guise T.A., Mohammad K.S., Clines G., Stebbins E.G., Wong D.H., Higgins L.S., et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clinical Cancer Research 12 (2006) 6213s-6216s
11. Herrmann E., Bögemann M., Bierer S., Eltze E., Toma M.I., Köpke T., et al. The role of the endothelin axis and microvessel density in bladder cancer-correlation with tumor angiogenesis and clinical prognosis. Oncology Reproduction 18 (2007) 133-138
12. James N.D., Borre M., Zonnenberg B., Beuzeboc P., Morris T., Phung D., et al. ZD4054, a potent, specific endothelin A receptor antagonist, improves overall survival in pain-free or mildly symptomatic patients with hormone-resistant prostate cancer (HRPC) and bone metastases. European Journal of Cancer (Suppl.) 5 (2007) 3
13. Kefford R., Beith J.M., Van Hazel G.A., Millward M., Trotter J.M., Wyld D.K., et al. A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma. Investigation New Drugs 25 (2007) 247-252
14. Mai H.Q., Zeng Z.Y., Zhang C.Q., Feng K.T., Guo X., Mo H.Y., et al. Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma. Cancer 106 (2006) 1548-1553
15. Masaki T. The endothelin family: An overview. Journal of Cardiovascular Pharmacolology 35 (2000) S3-S5
16. Nelson J.B., Bagnato A., Battistini B., and Nisen P. The endothelin axis: Emerging role in cancer. Nature Review Cancer 3 (2003) 110-116
17. Peduto Eberl L., Bovey R., and Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. British Journal of Cancer 88 (2003) 788-795
18. Pflug B.R., Zheng H., Udan M.S., D'Antonio J.M., Marshall F.F., Brooks J.D., et al. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Letter 246 (2007) 139-148
19. Rosanò L., Spinella F., Salani D., Di Castro V., Venuti A., Nicotra M.R., et al. Therapeutic targeting of the endothelin A receptor in human ovarian carcinoma. Cancer Research 63 (2003) 2447-2453
20. Rosanò L., Spinella F., Di Castro V., Nicotra M.R., Albini A., Natali P.G., et al. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. American Journal of Pathology 163 (2003) 753-762
21. Rosanò L., Spinella F., Di Castro V., Nicotra M.R., Dedhar S., de Herreros A.G., et al. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Research 65 (2005) 11649-11657
22. Rosanò L., Di Castro V., Spinella F., Tortora G., Nicotra M.R., Natali P.G., et al. Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. Cancer Research 67 (2007) 6351-6359
23. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. Journal of Cell Physiology 213 (2007) 589-602
24. Smollich M., and Wulfing P. The endothelin axis: A novel target for pharmacotherapy of female malignancies. Current Vascular Pharmacology 5 (2007) 239-248
25. Spinella F., Rosanò L., Di Castro V., Decandia S., Nicotra M.R., Natali P.G., et al. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Research 67 (2007) 1725-1734
26. Sun P., Xiong H., Kim T.H., Ren B., and Zhang Z. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Molecular Pharmacology 69 (2006) 520-531
27. Vacca F., Bagnato A., Catt K.J., and Tecce R. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Research 60 (2000) 5310-5317